| | |
Control
| |
ENU
|
---|
| | |
NGS (this study)
| |
NGS (this study)
| |
Genome-wide screening1a
| |
Transgenic reporter gene mutation assays
|
Endogenous gene mutation assays
|
---|
Target sequences
| | |
Whole exome
| |
Whole exome
| |
63 loci (197 Mb)
| |
gpt (this study)
| |
gpt
2
| |
lacZ
3
| |
lacZ
4
| |
lacI
5
| |
Hprt (cDNA)6
| |
Hprt (exon 3)7
| |
---|
Target tissues
| | |
Offspring
|
Offspring
|
Offspring
|
Sperm
|
Bone marow
|
Liver
|
Bone marrow
|
Splenic lymphocytes
|
Splenic lymphocytes
|
Splenic lymphocytes
|
---|
Mutations
| | |
No.
|
%
|
No.
|
%
|
No.
|
%
|
No.
|
%
|
No.
|
%
|
No.
|
%
|
No.
|
%
|
No.
|
%
|
No.
|
%
|
No.
|
%
|
---|
Base substitution
| | | | | | | | | | | | | | | | | | | | | | |
Transition
| | | | | | | | | | | | | | | | | | | | | | |
G:C
|
to
|
A:T
|
1
|
33.3
|
21
|
17.1
|
32
|
22.4
|
11
|
22.4
|
17
|
28.3
|
6
|
24.0
|
7
|
35.0
|
13
|
29.5
|
4
|
12.9
|
2
|
3.9
|
A:T
|
to
|
G:C
|
1
|
33.3
|
52
|
42.3
|
53
|
37.1
|
8
|
16.3
|
12
|
20.0
|
1
|
4.0
|
2
|
10.0
|
10
|
22.7
|
7
|
22.6
|
14
|
27.5
|
Transversion
| | | | | | | | | | | | | | | | | | | | | | |
G:C
|
to
|
T:A
|
0
|
0.0
|
12
|
9.8
|
13
|
9.1
|
7
|
14.3
|
9
|
15.0
|
6
|
24.0
|
4
|
20.0
|
4
|
9.1
|
1
|
3.2
|
1
|
2.0
|
G:C
|
to
|
C:G
|
0
|
0.0
|
0
|
0.0
|
1
|
0.7
|
1
|
2.0
|
0
|
0.0
|
0
|
0.0
|
0
|
0.0
|
1
|
2.3
|
1
|
3.2
|
0
|
0.0
|
A:T
|
to
|
T:A
|
0
|
0.0
|
33
|
26.8
|
35
|
24.5
|
17
|
34.7
|
17
|
28.3
|
7
|
28.0
|
6
|
30.0
|
10
|
22.7
|
13
|
41.9
|
28
|
54.9
|
A:T
|
to
|
C:G
|
0
|
0.0
|
5
|
4.1
|
8
|
5.6
|
4
|
8.2
|
3
|
5.0
|
3
|
12.0
|
0
|
0.0
|
4
|
9.1
|
5
|
16.1
|
6
|
11.8
|
Deletion
| | |
1
|
33.3
|
0
|
0.0
|
1
|
0.7
|
1
|
2.0
|
2
|
3.3
|
1
|
4.0
|
1
|
5.0
|
1
|
2.3
|
0
|
0.0
|
0
|
0.0
|
Insertion
| | |
0
|
0.0
|
0
|
0.0
|
0
|
0.0
|
0
|
0.0
|
0
|
0.0
|
1
|
4.0
|
0
|
0.0
|
1
|
2.3
|
0
|
0.0
|
0
|
0.0
|
Total
| | |
3
|
100
|
123
|
100
|
143
|
100
|
49
|
100
|
60
|
100
|
25
|
100
|
20
|
100
|
44
|
100
|
31
|
100
|
51
|
100
|
-
1Male F1 mice by crossing C57BL/6 × DBA/2 or C3H/He [12]
-
2Male BDF1 gpt delta mice [10]
-
3Female CD2F1 MutaTM mice [17]
-
4Male CD2F1 MutaTM mice [18]
-
5Male B6C3F1 Big Blue® mice [19]
-
6C57BL/6 mice [30]
-
7Male B6C3F1 mice [19]
-
aTemperature gradient capillary electrophoresis (TGCE) and Sanger sequencing methods